PT1117401E - Composicoes antibioticas para o tratamento do olho - Google Patents

Composicoes antibioticas para o tratamento do olho

Info

Publication number
PT1117401E
PT1117401E PT99956504T PT99956504T PT1117401E PT 1117401 E PT1117401 E PT 1117401E PT 99956504 T PT99956504 T PT 99956504T PT 99956504 T PT99956504 T PT 99956504T PT 1117401 E PT1117401 E PT 1117401E
Authority
PT
Portugal
Prior art keywords
eye treatment
antibiotic compositions
antibiotic
compositions
eye
Prior art date
Application number
PT99956504T
Other languages
English (en)
Portuguese (pt)
Inventor
John M Yanni
Gerald Cagle
Robert L Abshire
David W Stroman
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26799441&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1117401(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of PT1117401E publication Critical patent/PT1117401E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT99956504T 1998-09-30 1999-09-29 Composicoes antibioticas para o tratamento do olho PT1117401E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10250698P 1998-09-30 1998-09-30
US10250498P 1998-09-30 1998-09-30

Publications (1)

Publication Number Publication Date
PT1117401E true PT1117401E (pt) 2004-03-31

Family

ID=26799441

Family Applications (5)

Application Number Title Priority Date Filing Date
PT99956504T PT1117401E (pt) 1998-09-30 1999-09-29 Composicoes antibioticas para o tratamento do olho
PT101764124T PT2269602E (pt) 1998-09-30 1999-09-29 Composições de antibiótico para o tratamento do ouvido
PT141763664T PT2796138T (pt) 1998-09-30 1999-09-29 Composições antibióticas para tratamento da conjuntivite
PT101786572T PT2301541E (pt) 1998-09-30 1999-09-29 Composições de antibiótico para o tratamento dos olhos
PT03020587T PT1384478E (pt) 1998-09-30 1999-09-29 Composi??es de antibi?tico que cont?m moxifloxacina para o tratamento dos olhos

Family Applications After (4)

Application Number Title Priority Date Filing Date
PT101764124T PT2269602E (pt) 1998-09-30 1999-09-29 Composições de antibiótico para o tratamento do ouvido
PT141763664T PT2796138T (pt) 1998-09-30 1999-09-29 Composições antibióticas para tratamento da conjuntivite
PT101786572T PT2301541E (pt) 1998-09-30 1999-09-29 Composições de antibiótico para o tratamento dos olhos
PT03020587T PT1384478E (pt) 1998-09-30 1999-09-29 Composi??es de antibi?tico que cont?m moxifloxacina para o tratamento dos olhos

Country Status (18)

Country Link
EP (5) EP1384478B1 (cg-RX-API-DMAC7.html)
JP (5) JP2002525317A (cg-RX-API-DMAC7.html)
KR (1) KR101463243B1 (cg-RX-API-DMAC7.html)
CN (2) CN1184968C (cg-RX-API-DMAC7.html)
AR (2) AR020661A1 (cg-RX-API-DMAC7.html)
AT (2) ATE254458T1 (cg-RX-API-DMAC7.html)
AU (1) AU762827B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI9914151B1 (cg-RX-API-DMAC7.html)
CA (3) CA2659064A1 (cg-RX-API-DMAC7.html)
CY (3) CY1111404T1 (cg-RX-API-DMAC7.html)
DE (2) DE69912972T2 (cg-RX-API-DMAC7.html)
DK (5) DK2269602T3 (cg-RX-API-DMAC7.html)
ES (4) ES2526521T3 (cg-RX-API-DMAC7.html)
HK (1) HK1038691B (cg-RX-API-DMAC7.html)
PT (5) PT1117401E (cg-RX-API-DMAC7.html)
TR (2) TR200100883T2 (cg-RX-API-DMAC7.html)
TW (1) TWI222361B (cg-RX-API-DMAC7.html)
WO (1) WO2000018386A2 (cg-RX-API-DMAC7.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
MXPA02003130A (es) 1999-09-24 2004-04-21 Alcon Inc Formulaciones topicas en suspension que contienen ciprofloxacino y dexametasona.
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
WO2001089495A2 (en) * 2000-05-19 2001-11-29 Alcon Laboratories, Inc. Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
US6462033B2 (en) 2000-07-26 2002-10-08 Alcon Universal Ltd. Process for manufacturing compositions containing ciprofloxacin and hydrocortisone
WO2002040028A1 (fr) * 2000-11-16 2002-05-23 Wakamoto Pharmaceutical Co., Ltd. Gouttes pour les yeux en gel antibacterien
WO2002049633A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Use of amidoamines to treat or prevent acanthamoeba and fungal infections
AU2002226926A1 (en) * 2000-12-20 2002-07-01 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
DE60208216T2 (de) 2001-09-21 2006-06-29 Alcon Inc. Verfahren zur behandlung von mittelohrinfektionen
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US7514451B2 (en) 2003-09-10 2009-04-07 Kyorin Pharmaceutical Co., Ltd. 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
AU2005282571A1 (en) * 2004-09-03 2006-03-16 Piedmont Pharmaceuticals, Llc Methods for transmembrane treatment and prevention of otitis media
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
KR20070089222A (ko) * 2004-12-10 2007-08-30 알콘, 인코퍼레이티드 귀 감염을 치료하기 위한 조성물
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
TWI495469B (zh) 2008-06-09 2015-08-11 Alcon Res Ltd 含有氟喹諾酮抗生素藥物之經改良藥學組成物
AU2010266120B2 (en) * 2009-07-02 2014-02-06 Curofin Pharma Gmbh Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
WO2011085209A2 (en) * 2010-01-07 2011-07-14 Regents Of The University Of Minnesota Methods and compositions for applying moxifloxacin to the ear
BR112014012885A2 (pt) 2011-12-06 2017-06-13 Alcon Res Ltd composição de gel celulósica com estabilidade de viscosidade aperfeiçoada
RU2472507C1 (ru) * 2012-02-01 2013-01-20 Закрытое акционерное общество "Брынцалов-А" Водный состав на основе моксифлоксацина для парентерального введения
US9504691B2 (en) 2012-12-06 2016-11-29 Alcon Research, Ltd. Finafloxacin suspension compositions
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
CN104224802B (zh) * 2014-09-19 2017-12-12 南京优科生物医药研究有限公司 一种盐酸莫西沙星滴耳剂及其制备方法
RU2595837C2 (ru) * 2014-09-29 2016-08-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазных капель
CN108348516B (zh) * 2015-10-29 2021-02-12 特一华制药株式会社 外用剂
US20210386759A1 (en) * 2020-06-10 2021-12-16 Ocular Science, Inc. Compositions and methods for post-operative ocular care
WO2019193513A1 (en) * 2018-04-03 2019-10-10 Hyderabad Eye Research Foundation Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics
IT201900005280A1 (it) * 2019-04-05 2020-10-05 Ntc S R L Composizione otologica
CN116270662A (zh) * 2021-12-03 2023-06-23 苏州欧康维视生物科技有限公司 盐酸莫西沙星地塞米松磷酸钠滴眼液
KR102656260B1 (ko) 2022-10-14 2024-04-09 주식회사태준제약 목시플록사신을 포함하는 안과용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
CA1325382C (en) * 1988-01-27 1993-12-21 Takahiro Ogawa Locally administrable therapeutic composition for inflammatory disease
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
AU4201189A (en) * 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
JPH03109236A (ja) * 1989-09-22 1991-05-09 Hoya Corp 半導体超微粒子分散ガラスの製造方法
JPH085779B2 (ja) * 1989-09-22 1996-01-24 杏林製薬株式会社 フレロキサシン点眼液
TW209865B (cg-RX-API-DMAC7.html) * 1992-01-10 1993-07-21 Bayer Ag
CA2132826C (en) 1992-05-06 1999-01-05 Masood Chowhan Use of borate-polyol complexes in ophthalmic compositions
DE4424369A1 (de) * 1994-07-11 1996-01-18 Bayer Ag Pyrido[3,2,1.i,j][3,1]benzoxazinderivate
JPH0892241A (ja) * 1994-09-22 1996-04-09 Ss Pharmaceut Co Ltd ５−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
DE69620136T2 (de) * 1995-06-06 2002-08-01 Bayer Ag Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen
JP3290914B2 (ja) * 1997-03-17 2002-06-10 参天製薬株式会社 眼組織におけるキノロン系抗菌剤の定量装置
DK1017392T3 (da) * 1997-09-25 2002-10-21 Bayer Ag Lægemiddel
DE69922817T2 (de) 1998-09-23 2005-06-16 Unilever N.V. Orale zusammensetzung mit verbessertem bleichendem effekt
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
KR20010107754A (ko) * 2000-05-26 2001-12-07 민경윤 경구투여용 속용정의 제조 방법

Also Published As

Publication number Publication date
HK1150756A1 (en) 2012-01-13
DE69912972D1 (de) 2003-12-24
EP2796138A1 (en) 2014-10-29
KR20010075138A (ko) 2001-08-09
CN1184968C (zh) 2005-01-19
CN1650863A (zh) 2005-08-10
EP2301541B1 (en) 2014-08-20
PT1384478E (pt) 2011-05-12
EP1117401B1 (en) 2003-11-19
TR200100883T2 (tr) 2001-10-22
CA2774207A1 (en) 2000-04-06
AU762827B2 (en) 2003-07-03
DK2301541T3 (da) 2014-09-01
EP2301541A1 (en) 2011-03-30
DK2796138T3 (en) 2016-12-05
ES2602956T3 (es) 2017-02-23
HK1059572A1 (en) 2004-07-09
PT2796138T (pt) 2016-09-22
WO2000018386A2 (en) 2000-04-06
TWI222361B (en) 2004-10-21
PT2269602E (pt) 2014-12-29
CN1320035A (zh) 2001-10-31
EP1384478A1 (en) 2004-01-28
AU1310100A (en) 2000-04-17
CA2659064A1 (en) 2000-04-06
DK1117401T3 (da) 2004-02-23
CA2342211A1 (en) 2000-04-06
ATE254458T1 (de) 2003-12-15
JP2013018799A (ja) 2013-01-31
EP2269602A1 (en) 2011-01-05
BRPI9914151B8 (cg-RX-API-DMAC7.html) 2021-05-25
DK1384478T3 (da) 2011-05-23
JP2014144982A (ja) 2014-08-14
JP2002525317A (ja) 2002-08-13
DK2269602T3 (en) 2014-12-15
DE69912972T2 (de) 2004-04-22
HK1150769A1 (en) 2012-01-13
BRPI9914151B1 (pt) 2017-10-03
CY1111404T1 (el) 2015-08-05
PT2301541E (pt) 2014-10-29
CA2342211C (en) 2009-05-26
KR101463243B1 (ko) 2014-12-17
CY1115759T1 (el) 2017-01-25
EP1117401A2 (en) 2001-07-25
TR200704370T2 (tr) 2007-11-21
BR9914151A (pt) 2001-06-26
ES2519190T3 (es) 2014-11-06
EP2796138B1 (en) 2016-08-17
JP2012067141A (ja) 2012-04-05
DE69943287D1 (de) 2011-04-28
WO2000018386A3 (en) 2000-06-08
AR020661A1 (es) 2002-05-22
ES2526521T3 (es) 2015-01-13
CN100374114C (zh) 2008-03-12
EP2269602B1 (en) 2014-11-19
CY1115916T1 (el) 2017-01-25
AR081393A2 (es) 2012-08-29
ES2207307T3 (es) 2004-05-16
HK1038691A1 (en) 2002-03-28
HK1038691B (en) 2004-04-23
EP1384478B1 (en) 2011-03-16
JP5563041B2 (ja) 2014-07-30
JP2009007375A (ja) 2009-01-15
ATE501732T1 (de) 2011-04-15

Similar Documents

Publication Publication Date Title
PT1117401E (pt) Composicoes antibioticas para o tratamento do olho
NO20011738L (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
BR9707609A (pt) Composição para desinfecção
PT956858E (pt) Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
PT1005356E (pt) Novos agentes antibacterianos
ATE279190T1 (de) Synergistische zusammensetzungen zur krebsbehandlung
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
DE69937339D1 (de) Bakterizide
ID29430A (id) Komposisi herbisida
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
DE69928862D1 (de) Zusammensetzung
DE69942892D1 (de) Gaserzeugende zusammensetzung
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO20020319D0 (no) Oftalmisk sammensetning
PT1124567E (pt) Composicoes tamponadas para dialise
NO20020621D0 (no) Antibakterielle midler
NO20003786D0 (no) Oftalmisk sammensetning
ATE248579T1 (de) Synergistische antibakterielle kombination
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
PT1051172E (pt) Metodo para tratamento da dpco
BR0114005B1 (pt) composição para tratamento de tecido
DE69605988D1 (de) Synergistische antimikrobielle Zusammensetzung
ID26295A (id) Komposisi keras-ultraviolet
DE10080787D2 (de) Mikrobiozide Zusammensetzung